Clinical and laboratory characteristics of patients with adrenal incidentalomas in the differential diagnosis of subclinical hypercortisolism
DOI:
https://doi.org/10.12775/JEHS.2020.10.11.023Keywords
adrenal incidentaloma, subclinical hypercortisolism, subclinical Cushing's syndrome, autonomic cortisol secretion, primary hyperaldosteronismAbstract
Clinical and laboratory characteristics of patients with adrenal incidentalomas in the differential diagnosis of subclinical hypercortisolism. O. E. Tretyak.
Purpose. Determination of the prevalence of subclinical Cushing's syndrome among patients with adrenal incidentalomas; determination of the diagnostic consideration of clinical and laboratory parameters used for the diagnosis of endogenous subclinical hypercortisolism.
Methods. Retrospective analysis of data from 310 patients, who underwent a surgery for unilateral/bilateral adrenal masses. A comparative analysis of the two groups was carried out; the groups were divided based on the results of postoperative pathohistological study. Group 1 included 244 patients with hormonally active masses - adenomas (210), PBMAH (31), PPNAD (3); Group 2 included 66 patients with inactive masses. There were assessed the prevalence of hypertension, DM 2, overweight and the results of laboratory studies of the cortisol level after dexamethasone suppressive test, ACTH, and daily urine-free cortisol excretion.
Results. Patients with hormonally active masses are older (mean age is 52.7 years); 68.4% of patients in group 1 haveAH, 27% haveDM2 (group 2, respectively, 36.4% and 13.6%). There are no differences between groups as to the presence of overweight and obesity. 22.5% of patients of group 1 were confirmed to havePA, in most cases against the background of bilateral masses. The parameter of cortisol after DST has the best diagnostic consideration – sensitivity 90.2%, specificity 74% at a cut-off point level of 1.7 μcg/dL; for ACTH <10 pg/mL, the sensitivity is 71.4% and the specificity is 92.6%. Daily cortisol urine-free excretion has the third most significant diagnostic consideration (sensitivity 71.4%, specificity 81.8%, COP 238 mg/24 h.), which limits the application of this parameter for the confirmation of high levels of cortisol in patients with incidentalomas. Cases of bilateral adrenal hyperplasia should be considered as a probable variant of PBMAH syndrome, requiring further laboratory testing for PA.
References
Di Dalmazi G, Vicennati V, Garelli S, Casadio E. et al Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study//Lancet Diabetes Endocrinol.- 2014 May;2(5):396-405.
Debono M., BradbumM.,BullM.Cortisol as a Marker for Increased Mortality in Patients with Incidental Adrenocortical Adenomas// J ClinEndocrinol. Metab. 2014. Vol.99(12). - P.4462-4470.
Morelli V, Scillitani A, Arosio M, ChiodiniI. Follow-up of patients with adrenal incidentaloma, in accordance with the European society of endocrinology guidelines: Could we be safe?//.J Endocrinol Invest. 2017 Mar.
Antoine Tabarin.Do the diagnostic criteria for subclinical hypercortisolism exist?//2018 Jun/79(3):146-148.
Henning Dralle, John Newell-Price, Antoine Tabarin et al. Мanagement of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors//Euro J Endocrinol. - 2016.
Hong AR, Kim JH, Park KS, Kim KY, Lee JH, Kong SH, Lee SY, Shin CS, Kim SW.Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice.//Eur J Endocrinol. 2017 Dec;177(6):475-483.
Farrugia FA, Misiakos E, Martikos G, Tzanetis P, Charalampopoulos A, Zavras N, Sotiropoulos D, KoliakosN.Rom . A step by step approach in differential diagnosing of adrenal incidentaloma (epinephroma), (with comments on the new Clinical Practice Guidelines of the European Society of Endocrinology).// J Intern Med. 2017 Dec
Choi K.M., Seu J.H., Kim Y.H., Lee E.J., Kim S.J., Bike S.H. et al. Cushing's syndrome caused by primary pigmented nodular adrenocortical disease: a case report and literature review //Korean J Intern Med.- 1995.
Shigemitsu Yasuda, Yusuke Hikima, Yusuke Kabeya, Shinichiro Iida. Clinical characterization of patients with primary aldosteronism plus subclinical Cushing's syndrome//BMC EndocrDisord 2020 Jan 13;20(1):9.
Cherenko S.M., Tretyak O.E., Tovkai O.A. Adrenokorticotropin-independent macronodular adrenal hyperplasia: the first clinical experience in Ukraine//Clinical endocrinology and endocrine surge. 2016 .2 (54) . S. 85-93.
Araujo-Castro M, SampedroNúñez MA, Marazuela M. Autonomous cortisol secretion in adrenal incidentalomas. Endocrine. 2019 Apr;64(1):1-13.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 586
Number of citations: 0